Julia Lord is currently a Senior Director of Oncology R&D Strategy focused on Cell Therapy at AstraZeneca, having begun this role in 2025. Before joining AstraZeneca, they served as Associate Director of Business Development at LifeMine Therapeutics and contributed to the Nucleate Spring 2023 Activator Team for the startup DianomBio. Julia's previous experience includes roles at ClearView Healthcare Partners and bluebird bio, where they advised on various aspects of pharmaceutical strategy and development. They earned their Bachelor of Arts in Neurobiology and are currently pursuing both a Master of Science in Biotechnology and an MBA at Harvard University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices